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Abstract
Background: During inflammatory conditions of the central nervous system (CNS), such as in
multiple sclerosis or in its animal model, experimental autoimmune encephalomyelitis (EAE),
immune cells migrate from the blood stream into the CNS parenchyma and into the cerebrospinal
fluid (CSF) spaces. The endothelial blood-brain barrier (BBB) has been considered the most
obvious entry site for circulating immune cells. Recently, the choroid plexus has been considered
as an alternative entry site for circulating lymphocytes into the CSF. The choroid plexus, belongs
to the circumventricular organs (CVOs) localized in the walls of the ventricles. Other CVOs, which
similar to the choroid plexus lack an endothelial BBB, have not been considered as possible entry
sites for immune cells into the CNS parenchyma or the CSF. Here we asked, whether CVOs are
involved in the recruitment of inflammatory cells into the brain during EAE.
Methods: We performed an extensive immunohistological study on the area postrema (AP), the
subfornical organ (SFO), the organum vasculosum of the lamina terminalis (OVLT) and the median
eminence (ME) in frozen brain sections from healthy SJL mice and mice suffering from EAE.
Expression of cell adhesion molecules, the presence of leukocyte subpopulations and the detection
of major histocompatibility complex antigen expression was compared.
Results: Similar changes were observed for all four CVOs included in this study. During EAE
significantly increased numbers of CD45+  leukocytes were detected within the four CVOs
investigated, the majority of which stained positive for the macrophage markers F4/80 and Mac-1.
The adhesion molecules ICAM-1 and VCAM-1 were upregulated on the fenestrated capillaries
within the CVOs. A considerable upregulation of MHC class I throughout the CVOs and positive
immunostaining for MHC class II on perivascular cells additionally documented the immune
activation of the CVOs during EAE. A significant enrichment of inflammatory infiltrates was
observed in close vicinity to the CVOs.
Conclusion: Our data indicate that the CVOs are a site for the entry of immune cells into the
CNS and CSF and consequently are involved in the inflammatory process in the CNS during EAE.
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Background
In multiple sclerosis and in its animal model, experimen-
tal autoimmune encephalomyelitis (EAE), inflammatory
cells obtain access to the central nervous system (CNS)
parenchyma and the cerebrospinal fluid (CSF) and initi-
ate the events leading to signs of paralysis. The endothelial
blood-brain barrier (BBB) has been considered the obvi-
ous place for entry for circulating lymphocytes into the
CNS. Therefore most investigations have focused on
defining the molecular mechanisms involved in leukocyte
recruitment from the circulating blood across the
endothelial BBB. The adhesion molecules, intercellular
adhesion molecule 1 (ICAM-1) and vascular cell adhesion
molecule 1 (VCAM-1), both members of the immu-
noglobulin superfamily, are upregulated on the endothe-
lial cells of cerebral vessels during EAE and actively
involved in the recruitment of inflammatory cells across
the BBB (summarized in [1]).
Trafficking pathways for the entry of immune cells into
the CSF remain unknown to date. The CSF of healthy indi-
viduals contains between 150,000 cells and 500,000 cells.
During multiple sclerosis this number increases dramati-
cally. Neither in the healthy individual nor during multi-
ple sclerosis does the cellular composition of the CSF
reflect that of the peripheral blood, suggesting a stringent
control for leukocyte entry into the CSF at all times [2].
Recently it was considered that leukocytes enter the CSF
using a direct pathway through the choroid plexus. The
microvessels within the choroid plexus are different to
those in brain parenchyma, the most significant of which
is that the endothelial cells allow free movement of mole-
cules via fenestrations and intercellular gaps (reviewed in
[3]). Instead, the barrier is located at the level of the
choroid plexus epithelial cells, which form tight junctions
inhibiting paracellular diffusion of water soluble mole-
cules [4].
Migration of leukocytes through the choroid plexus into
the CSF has been suggested by the finding that fluores-
cently labeled splenocytes are present in the choroid
plexus stroma two hours after intravenous injection in
mice [5]. The adhesion molecules ICAM-1 and VCAM-1,
which are required for leukocyte entry into the CNS, are
expressed on the choroid plexus epithelium [6], become
upregulated during EAE, and can mediate lymphocyte
binding in vitro [7]. These observations suggest that the
choroid plexus is involved in the communication of the
immune system with the CNS probably by allowing the
entry of immune cells directly into the CSF spaces.
Besides the choroid plexus there are additional structures
in the CNS of mammals lacking an endothelial BBB.
These areas fulfill neurohemal and neurosecretory func-
tions, in that the neurons monitor hormonal stimuli and
other substances within the blood or secrete neuroendo-
crines into the blood, and are commonly referred to as the
circumventricular organs (CVOs; reviewed in [8,9]).
CVOs are localized at strategic points close to the midline
of the brain within the ependymal walls lining the 3rd and
the 4th ventricle. Because they lack an endothelial BBB
they lie within the blood milieu and thus form a blood-
CSF barrier. At the cellular level the barrier between the
CVOs and the neuropil is established by specialized epi-
thelial cells called tanycytes. The median eminence (ME)
belongs to the purely neuroendocrine CVOs also includ-
ing the pineal gland and the neurohypophysis. The ME is
localized between the stem of the infundibular or pitui-
tary stalk of the hypophysis and the hypothalamus at the
base of the 3rd ventricle. The ME contains the terminations
of axons from hypothalamic neurons and specialized glial
cells. Neuroendocrine functions of the ME include the
release of gonadotropin-releasing hormone by which the
ME influences reproductive functions [10].
The sensory CVOs such as the subfornical organ (SFO),
the organum vasculosum of the lamina terminalis (OVLT)
and the area prostrema (AP) are characterized by a high
density of small neurons, astrocytes and microglial cells
[11]. The SFO and the OVLT are structures in the anterior
wall of the 3rd cerebral ventricle. The SFO bulges from the
roof of the 3rd ventricle into its lumen at the level of the
interventricular foramina, whereas the OVLT is localized
in the lamina terminalis between the chiasma opticum
and the anterior commissure. The AP can be found at the
caudal end of the fossa rhomboidea in the floor of the 4th
ventricle. The sensory CVOs monitor the changes in
osmotic, ionic and hormonal composition of the blood
and are therefore involved in regulating thirst and fluid
metabolism [12].
The strategic localization of the CVOs in the wall of the
ventricles prompted us to ask whether the CVOs might,
similar to the choroid plexus, be involved in the recruit-
ment of immune cells into the brain during EAE. We have
performed an extensive immunohistological study local-
izing adhesion molecules, MHC class I and II antigens and
leukocyte subpopulations within the subfornical organ
(SFO), the median eminence (ME), the organum vasculo-
sum of the lamina terminalis (OVLT) and the area pos-
trema (AP) of the SJL/N mouse. During EAE similar
changes were observed within all four CVOs included in
this study. Specifically, the presence of significantly
increased numbers of CD45+ leukocytes in the CVOs sug-
gested the recruitment of inflammatory cells into the the
parenchyma of the CVOs probably mediated via endothe-
lial ICAM-1 and VCAM-1 which were both upregulated on
the microvessels within the CVOs. These changes were
accompanied by a significant upregulation of MHC class I
throughout the CVOs and induction of MHC class II onCerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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perivascular cells. Our observations indicate an active
communication between the CVOs and the CNS paren-
chyma and thus the involvement of the CVOs in the
inflammatory process of the CNS during EAE.
Methods
Induction of EAE
Female SJL/N mice were obtained from Bomholdgård
Breeding, Ry, Denmark and used for experiments at the
age of 10 weeks. Active EAE (aEAE) was induced by immu-
nization with syngeneic spinal cord homogenate as
described in detail before [13,14]. Briefly, SJL/N mice
were immunized with 100 µg of spinal cord homogenate
(SCH) from syngeneic mice in complete Freund's Adju-
vant (CFA) (Gibco Laboratories, Grand Island, NY), con-
taining 60 µg/ml Mycobacterium tuberculosis H37Ra and 10
µg/ml  Mycobacterium butyricum (Difco Laboratories,
Detroit, MI) subcutaneously. Heat-killed Bordetella pertus-
sis  organisms (3 × 109; kindly provided by Dr. Kolbe,
Behring Werke, Marburg, Germany or Dr. Kohler, Berna
Biotech, Bern, Switzerland) were injected in 0.5 ml of PBS
on days 1 and 3 post immunization. Animals were
checked daily and clinical severity was documented as fol-
lows: 0.5 = limp tail; 1 = weak hindlimbs, unsteady gate;
2 = paraplegic, 3 = paraplegic plus incontinent and weak-
ness. Clinical disease occurred approximately 14 days post
immunization with spinal cord homogenate. A total of 46
mice with a clinical severity of EAE of 1 to 2 during their
first clinical episode are presented in this study. As con-
trol, 10 untreated littermates, which were kept in the same
cages – were sacrificed and investigated in the same way.
All animal experiments were performed in accordance
with the German and the Swiss legislation on the protec-
tion of animals and approved by the respective govern-
ment authorities (permission numbers B2/127 and 55/
04).
Monoclonal Antibodies
Mec13.3 (anti-mouse PECAM-1/CD31), MK2.7 (anti-
mouse VCAM-1), 3C4 (anti-mouse ICAM-2), RB40.34/4
(anti-mouse P-selectin), Lyt 2 (anti-mouse CD8), 145-
2C11 (anti-mouse CD3), F4/80 (anti-mouse macro-
phages), FD441.8 (anti-mouse LFA-1), Mel-14 (anti
mouse L-selectin) were purchased form BD Pharmingen,
Germany, where detailed information on the antibodies
can be obtained http://www.bdbiosciences.com/
pharmingen. C363 (anti mouse CD3ε) was purchased
from Southern Biotechnology Associates, Birmingham,
AL, USA, http://www.southernbiotech.com. ER-TR2 (rat-
anti mouse MHC class II) and ER-MP42 (rat anti-mouse
MHC class I) were purchased from Dianova, Hamburg,
Germany, http://www.dianova.com/index_flash.php. The
hybridomas PS/2 (anti-mouse α4-integrin), M1/9 (anti-
mouse CD45), M1/70 (anti-mouse Mac-1), B220 (anti-
mouse CD45R), GK1.5 (anti-mouse CD4), MECA-367
and MECA-89 (anti- mouse MAdCAM-1) and Hermes-1
(= 9B5, anti-human CD44, used as an isotype-matched
control) were obtained from ATCC (Rockville, MA, USA;
http://www.atcc.org). 25ZC7 (anti-mouse ICAM-1) and
9DB3 (anti-mouse VCAM-1) were kindly provided by D.
Vestweber (Münster, Germany; [13]. UZ 4 and UZ 7 (both
anti-mouse E-selectin) and MECA 32 were kindly pro-
vided by R. Hallmann (Münster, Germany; [14,15]).
Immunohistochemistry
Animals were anesthetized using isoflurene anesthesia
(Abbott, Wiesbaden, Germany), and were perfused with
either phosphate buffered saline (PBS) or 1% formalde-
hyde (PFA) in PBS through the left ventricle of the heart.
Tissue was removed, embedded in Tissue-tec, (OCT, Miles
Inc., Vogel, Giessen, Germany), and snap-frozen in a 2-
methylbutane (Merck, Darmstadt, Germany) bath at -
80°C. Cryostat sections (6 µm) were air dried overnight,
acetone fixed, and stained using a three-step immunoper-
oxidase technique. Sections were incubated sequentially
with primary mAbs, biotinylated secondary goat-anti-rat
IgG, (Vector, Boehringer Ingelheim Bioproducts, Heidel-
berg, Germany), and horseradish peroxidase-conjugated
Streptavidin (Vector) for 30 min each step in a humidified
chamber, with PBS washes in between the single steps.
Sections were developed with 0.07% amino-ethylcarbazol
(AEC, Sigma, Germany) and 0.009% hydrogen peroxide
in 0.01 M acetate buffer (pH 5.2) for 10 min. Sections
were counterstained with Hematoxylin (Gill's formula,
Merck), coverslipped with Aquatex (Merck, Darmstadt,
Germany) and immediately analyzed.
To detect presence of luminal antigens in cerebral blood
vessels mice were injected intravenously with 250 µg pri-
mary antibody, anesthetized 15 or 30 minutes later, per-
fused first with PBS to remove unbound antibody then
with 1% PFA to fix bound antibody. Tissue was processed
as described above and immunohistology was performed
accordingly leaving out the first antibody. This study sum-
marizes results from a total of 49 individual immunos-
tainings where CVOs from 46 EAE mice and 10 healthy
mice were compared.
Results
In the mouse the panendothelial antigen MECA-32
becomes specifically downregulated in brain endothelia
during the maturation of the blood-brain barrier [15]. As
a consequence, the MECA-32 antigen was absent on the
mature cerebral endothelium, whereas it remained
present on vessels outside of the CNS and the microves-
sels within the choroid plexus and the circumventricular
organs (CVOs, Figures 1, 2, 3, 4, 5, 6, 7, 8).
In the present study we investigated four CVOs, namely
the subfornical organ (SFO), the area postrema (AP), theCerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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Immunohistology of the subfornical organ (SFO) in the  healthy SJL mouse Figure 1
Immunohistology of the subfornical organ (SFO) in 
the healthy SJL mouse. The top panel shows MECA-32+ 
capillaries within the SFO. Panels below demonstrate that 
ICAM-1 and VCAM-1 can not be detected on the MECA-32+ 
capillaries within the SFO. Single CD45+ perivascular cells can 
be detected within the SFO (open arrows, lower panel). 
Note the positive immunostaining for MECA-32 on choroid 
plexus capillaires and for ICAM-1 and VCAM-1 on the 
choroid plexus epithelium visible at the left and right margins 
(closed arrows). Immunoperoxidase, hematoxylin counter-
stain. Bar = 100 µm. This result was observed 10 times.
Immunohistology of the area postrema (AP) in the healthy  mouse Figure 2
Immunohistology of the area postrema (AP) in the 
healthy mouse. The V-shaped area of the AP is outlined by 
the MECA-32+ capillaries (top panel). ICAM-1 and VCAM-1 
can not be detected on the MECA-32+ capillaries within the 
AP. Single CD45+ perivascular cells are present in this CVO 
(e.g. arrows, lower panel). Immunoperoxidase, hematoxylin 
counterstain. Bar = 100 µm. This result was observed 10 
times.Cerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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median eminence (ME) and the organum vasculosum of
the lamina terminalis (OVLT), which all lack an endothe-
lial blood-brain barrier (BBB) and demonstrate fenes-
trated MECA-32+ microvessels.
The circumventricular organs in healthy SJL/N mice
In general, characteristics of the 4 CVOs analyzed were
similar. As expected in the healthy SJL/N mice we detected
MECA-32+ microvessels within the SFO (Fig. 1), in the AP
(Fig. 2) and the ME and OVLT (Table 1). Additionally,
CVO microvessels stained positive for PECAM-1 and
some of them stained for ICAM-2 (Table 1). Adhesion
molecules such as ICAM-1 and VCAM-1 (Figs. 1, 2 and
Table 1) or MAdCAM-1, E- and P-selectin (Table 1) could
not be detected on the microvessels within the CVOs of
healthy mice. A low number of CD45-positive perivascu-
lar cells was regularly observed in all CVOs (Figs. 1, 2, 3
and Table 1). In contrast, in only 1 or 2 out of 10 immu-
nostainings performed for each CVO, were individual
perivascular cells staining positive for macrophage mark-
ers such as F4/80 or Mac-1 or MHC class I or II and LFA-1
detected in CVOs of healthy mice (Table 1). This suggests
a variable and rarely detectable presence of individual
perivascular macrophages within the CVOs during health.
In contrast, parenchymal staining for these molecules was
never detected in the CVOs of healthy mice. Similarly,
staining for CD3, CD4, CD8 or B220 was always negative
in the CVOs of healthy mice (Table 1).
The circumventricular organs during EAE in SJL/N mice
During EAE the changes observed within the four CVOs
analysed were overall very similar. The microvessels
within the CVOs retained their characteristic staining for
the MECA-32 antigen, PECAM-1 and ICAM-2 (Figs. 3, 4,
5, 6, 7, 8, Table 1). In contrast to healthy mice, a high
number of CD45+ cells could be detected within the CVOs
(Fig. 3, 4, 5, 6), with the most prominent increase of
CD45+ cells detected within the OVLT (Fig. 3). CD45+ cells
within all four CVOs were localized in close proximity to
microvessels and were also found within the CVO
parenchyma. Besides the intense CD45 staining on cells of
round appearance, a fainter immunostaining for CD45
was detected on cells with a more ramified appearance,
indicating that, in addition to the recruitment of CD45+
cells into these areas, CD45 might also be upregulated on
the resident microglial cells within the CVOs (Fig. 4, 5, 6).
In order to further characterize the CD45+ cells detected
within the CVOs during EAE we performed immunostain-
ing for T cell, B cell, and macrophage markers. A large
number of F4/80+ and Mac-1+ macrophages or microglial
cells were detected within the CVOs (Figs. 4, 5). Whereas
F4/80+ cells were exclusively detected adjacent to CVO
microvessels, Mac-1 positive cells could also be found
within the parenchyma of the different CVOs (Fig. 4 and
5). Mac-1 positive cells presented either as round cells or
cells with many processes, suggesting that Mac-1 was
detected on macrophages recruited into the CVOs and
also upregulated on resident microglial cells. Besides
macrophages, few B220+ B lymphocytes as well as few
CD3+ T lymphocytes could regularly be detected within
the CVOs during EAE, especially within the SFO (Fig. 4).
Most of the CD3 positive T cells recruited into the SFO
were CD4+ T helper cells as indicated by the detection of
mostly CD4+ but rarely CD8+ cells within this CVO during
EAE (Fig. 4 and Table 1).
The adhesion molecules from the integrin family, namely
leukocyte function-associated antigen (LFA)-1 (αLβ2-
integrin) and α4-integrins can be involved in inflamma-
tory cell recruitment across the BBB during EAE. Therefore
we investigated, whether CD45+ cells localized within the
CVOs also express these adhesion molecules. Whereas a
CD45+ cells in the organum vasculosum of the lamina termi- nalis (OVLT) Figure 3
CD45+ cells in the organum vasculosum of the lamina 
terminalis (OVLT). Some CD45+ cells, which are not 
exclusively associated with the MECA-32+ capillaries can be 
detected within the OVLT of healthy SJL mice (lower two 
panels; Ø = healthy control). During EAE there is an 
increased number of CD45+ cells present within the OVLT 
(upper two panels; EAE). Immunoperoxidase, hematoxylin 
counterstain. Bar = 100 µm. This result was observed in at 
least 10 individual stainings.Cerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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Immunohistology of the subfornical organ (SFO) during EAE Figure 4
Immunohistology of the subfornical organ (SFO) during EAE. During EAE, MECA-32+ capillaries within the SFO stain 
positive for ICAM-1 and VCAM-1 (left panels). A large number of CD45+ cells preferentially localized in close vicinity to the 
microvessels can be detected within the SFO (second column top panel). Whereas expression of MHC class I is upregulated 
throughout the SFO parenchyma seen as diffuse staining, MHC class II is solely induced on perivascular cells (second column 
middle and lower panel). The majority of CD45+ cells within the SFO during EAE are macrophages/microglial cells as deter-
mined by positive immunostaining for the β2-integrin Mac-1 and for F4/80 (third column top and middle panel). Note, whereas 
staining for Mac-1 can be detected on round and ramified cells throughout the SFO, staining for F4/80 remains restricted to 
perivascular cells. Besides macrophages, a low number of CD3+ T lymphocytes of the CD4 and CD8 (data not shown) subclass 
and B220+ B cells can be detected (right panels). Most of the immune cells present within the SFO stain positive for LFA-1, but 
negative for α4-integrins (not shown). Immunoperoxidase, hematoxylin counterstain. Bar = 100 µm. This result was observed 
in at least 10 individual stainings.Cerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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Immunohistology of the area postrema (AP) during EAE Figure 5
Immunohistology of the area postrema (AP) during EAE. MECA-32+ capillaries within the AP stain positive for ICAM-
1 and VCAM-1 during EAE. A large number of CD45+ cells can be detected within the AP, which are associated with the 
microvessels (e.g. filled arrows) or localized within the parenchyma (e.g. open arrows). The majority of those are macro-
phages/microglial cells as determined by positive immunostaining for F4/80 and Mac-1. Note, whereas staining for Mac-1 can be 
detected on cells throughout the AP, staining of F4/80 is only seen on perivascular cells. Immunoperoxidase, hematoxylin coun-
terstain. Bar = 100 µm. This result was observed in at least 10 individual stainings.Cerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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Immunohistology of the median eminence (ME) during EAE Figure 6
Immunohistology of the median eminence (ME) during EAE. MECA-32+ capillaries within the ME stain positive for 
ICAM-1 and VCAM-1. Positive staining for CD45+ can be detected throughout the ME, staining perivascular cells (examples 
marked by filled arrow) or parenchymal cells (example marked by open arrow). MHC class I is detectable within the entire ME, 
with parenchymal localization (closed arrows) as well as vessel associated (open arrow). MHC class II is only present on 
perivascular cells. Immunoperoxidase, hematoxylin counterstain. Bar = 100 µm. This result was observed in at least 10 individ-
ual stainings.Cerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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high number of LFA-1+ cells was detected in the CVOs
(Fig. 4), α4-integrin positive cells were detected only
rarely (Table 1).
Next we asked whether the potential endothelial ligands
for Mac-1, LFA-1 and α4-integrins, namely intercellular
adhesion molecule (ICAM)-1 and vascular cell adhesion
molecule (VCAM)-1, are expressed on the microvascular
endothelial cells within the CVOs. We found prominent
induction of ICAM-1 and to a lesser degree of VCAM-1
(Figs. 4, 5, 6), but not of mucosal addressin cell adhesion
molecule (MAdCAM)-1, E-selectin or P-selectin (Table 1)
on CVO microvessels during EAE. In order to evaluate,
whether ICAM-1 and VCAM-1 are available on the lumi-
nal surface of the CVOs capillary endothelial cells for the
recruitment of circulating Mac-1+, LFA-1+ and α4-integrin+
leukocytes into the CVOs, we injected anti-ICAM-1 or
anti-VCAM-1 antibodies into live animals suffering from
EAE and investigated their binding to CVO microvessels
by immunohistology. Whereas ICAM-1 was detected on
the luminal surface of the capillaries of all CVOs investi-
gated (Figs. 7, 8 and data not shown), VCAM-1 although
present on the luminal surface of microvessels in the SFO,
OVLT and AP (Fig. 7 and data not shown) could not be
detected on the luminal surface of the capillaries within
the ME (Fig. 8). Taken together, these observations suggest
that recruitment of inflammatory cells into the CVOs
mainly depend on LFA-1/ICAM-1 or Mac-1/ICAM-1
rather than VCAM-1/α4-integrin-mediated interactions.
In addition to the increased number of immunocompe-
tent cells present in the CVOs during EAE, we observed a
significant upregulation of major histocompatibility com-
plex (MHC) antigens class I on cells throughout the entire
parenchyma of the CVOs, where expression was absent
before in healthy mice (Figs. 4, 6 and Table 1). In contrast,
expression of MHC class II was solely induced on perivas-
cular cells, a significant number of which could now reg-
ularly be found within all four CVOs during EAE (Fig. 4, 6
and Table 1).
Finally, besides the leukocyte infiltration of the CVOs
proper, we observed the preferential localization of mas-
sive inflammatory cuffs within the brain parenchyma or
the ventricular walls localized in close vicinity or directly
adjacent to CVOs, suggesting an involvement of the CVOs
in immune cell recruitment into these distinct areas (Fig.
9).
Discussion
In the present study we provide evidence that immune cell
invasion into the CNS during EAE is accompanied by a
prominent immune activation of the CVOs. Changes
within the CVOs are characterized by the presence of an
increased number of CD45+  cells, the considerable
induction of MHC class I and MHC class II molecules
within the CVOs as well as microglial activation docu-
mented by increased expression of Mac-1. Upregulated
expression of adhesion molecules on the CVO
Detection of luminal ICAM-1 and VCAM-1 in the capillaries of the SFO during EAE Figure 7
Detection of luminal ICAM-1 and VCAM-1 in the capillaries of the SFO during EAE. Mice suffering from EAE were 
perfused intravascularly with antibodies directed against MECA-32, ICAM-1 or VCAM-1; an irrelevant rat IgG was perfused as 
control. Bound antibody was detected by immunohistology. Only a subpopulation of capillaries within the SFO stain positive 
for luminal ICAM-1 and VCAM-1. Immunoperoxidase, hematoxylin counterstain. Bar = 100 µm. This result was observed 3 
times.Cerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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microvessels suggest their involvement in the recruitment
of macrophages, T- and B cells into the CVOs during EAE.
Taken together, these observations indicate an active par-
ticipation of the CVOs in the immunopathogenesis of
EAE.
The involvement of CVOs in the communication of the
immune system with the nervous system has been consid-
ered before. Due to their fenestrated capillaires the CVOs
are often referred to as "windows of the brain" and have
been thought to serve as entry points for pro-inflamma-
tory cytokines into the CNS [16]. In fact, receptors for
inflammatory cytokines and bacterial fragments are con-
stitutively expressed in cells within the sensory CVOs and
the release of pro-inflammatory cytokines such as
interleukin-1 or TNF-α outside the CNS has been demon-
strated to deliver signals into the CNS via the CVOs
leading to neuroendocrine responses such as elevations in
adrenocorticotropic hormone (ACTH) in the plasma,
development of fever and the activation of the hypotha-
lamic-pituitary-adrenal (HPA) axis [17]. Additionally,
CVOs play an active role in the development of brain
dysfunction during sepsis. Induction of experimental
endotoxin shock by injection of lipopolysaccaride
induces the sequential expression of molecules involved
in innate immune responses such as CD14 or Toll-like
receptors first in the CVOs and subsequently in the brain
parencyhma (reviewed by [18]). Furthermore, involve-
ment of CVOs in the establishment of an acute phase
response during peripheral immune stimuli was demon-
strated [19]. Finally, a role for CVOs in sending signals
into the brain during systemic inflammation is supported
Detection of luminal ICAM-1 and VCAM-1 in the capillaries of the ME during EAE Figure 8
Detection of luminal ICAM-1 and VCAM-1 in the capillaries of the ME during EAE. Mice suffering from EAE were 
perfused intravascularly with antibodies directed against MECA-32, ICAM-1 or VCAM-1; an irrelevant rat IgG was perfused as 
control. Bound antibody was detected by immunohistology. Only ICAM-1, not VCAM-1, could be detected on the luminal sur-
face of a subpopulation of capillaries in the ME during EAE. Immunoperoxidase, hematoxylin counterstain. Bar = 100 µm. This 
result was observed 3 times.Cerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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by observations that lesions of CVOs block several com-
ponents of brain-controlled illness responses (i.e. fever or
neuroendocrine modifications) [20].
An active participation of CVOs in the auto-immun-
opathogenesis in EAE has not been reported to date. In the
present study, we found that CVOs in the healthy SJL/N
mouse presented a low number of perivascular CD45+
cells, probably macrophages, similar to other regions of
the CNS. We only occasionally detected expression of
MHC class I or MHC class II on individual perivascular
cells suggesting that MHC-positive cells rarely reside
within CVOs of healthy mice. Adhesion molecules associ-
ated with inflammation could not be detected. In con-
trast, during clinical EAE at the time when immune cells
have penetrated the BBB and perivascular infiltration of T
cells and macrophages is observed within the CNS
parenchyma, the CVOs demonstrated a dramatic increase
in the presence of CD45+ cells. As CD45 is upregulated on
activated microglial cells, which reside in high numbers in
CVOs [21], the increased number of CD45+ cells detected
within the CVOs during EAE is most probably due to both
the recruitment of circulating CD45+ immune cells from
the periphery into these areas and additionally to the
upregulation of CD45 on microglial cells residing within
the CVOs.
Most of the CD45+ cells also expressed the macrophage
marker F4/80 or Mac-1, which can be expressed on mac-
rophages or activated microglial cells. Based on the
immunological and morphological criteria, these cells
most probably can be classified as perivascular macro-
phages or ramified microglial cells, as classical parenchy-
mal microglial cells, as well as scattered rounded
macrophage-like cells. Activation of microglial cells by
upregulated expression of CD45 and induction of Mac-1
therefore parallels the events observed within the CNS
parenchyma protected by the BBB during EAE.
Table 1: Summary of the immunohistochemical characterization of CVOs in health and EAE
Molecule Healthy1 EAE2
Microvessels
MECA-32 + on all vessels + on all vessels
PECAM-1 + on all vessels + on all vessels
ICAM-2 + on some vessels + on some vessels
ICAM-1 No staining + on most vessels luminally and abluminally/perivascular
VCAM-1 No staining + on few vessels luminally and abluminally or perivascular no 
luminal VCAM-1 detected in ME
MAdCAM-1 No staining no staining
E-selectin no staining no staining
P-selectin no staining no staining
Immune cells
CD45 + on few perivascular cells + on many cells within the CVOs
CD3 no staining + on few round cells ca. 4 cells/section in SFO ca. 10 cells/
section in AP
CD4 no staining + on few round cells
CD8 no staining + on few round cells
B220 no staining + on few round cells
F4/80 only rarely observed on single perivascular cells* + on many exclusively perivascular cells
Mac-1 (αM-integrin) only rarely observed on single perivascular cells* + on round and branched cells located perivascularly and 
throughout the CVOs
LFA-1 (αL-integrin) only rarely observed on single perivascular cells* + on round and branched cells located perivascularly and 
throughout the CVOs
α4-integrin no staining very faint staining on few round cells – not regularly detected
MHC class I only rarely observed on few perivascular cells§ considerable staining throughout the CVOs; negative on 
endothelium
MHC class II only rarely observed on single perivascular cells* + on many perivascular cells
1All four CVOs were analysed in a total of 10 healthy mice. Results therefore summarize 10 immunostainings. 2A total of 46 mice has been analyzed. 
Staining for each marker in each CVO was observed at least 10 times. If not stated differently, stainings were repeatedly observed in all CVOs 
analysed. *Single immunopositive cells were observed in only 1 or 2 of 10 immunostainings. §Few immunopositive cells were observed in 2 out of 10 
immunostainings.Cerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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Microglial activation within the CVOs during EAE is fur-
ther supported by our observation that MHC class I
antigens were induced throughout the BBB-deficient
parenchyma in all CVOs. In addition, MHC class II mole-
cules could now regularly be detected on perivascular
microglial cells or macrophages within the CVOs, which
may function as a cellular barrier against blood-borne
pathogens. Thus, increased expression of MHC class I and
II molecules on microglial cells and perivascular macro-
phages, which are known characteristic immunopatho-
logical changes observed in the CNS parenchyma during
EAE, are similarly observed in the BBB-deficient areas of
the CVOs [22].
Besides the immune activation of the CVOs, recruitment
of a low number of CD3+ T cells and B220+ B cells was
detected in the parencyhma of CVOs during EAE, demon-
strating that immune cells are invading these areas during
EAE. It has been shown that endothelial VCAM-1 and
ICAM-1 are involved in lymphocyte recruitment across
brain endothelium in vitro and in vivo [13,23-25]. The
upregulated expression of ICAM-1 and VCAM-1 on the
microvessels of the CVOs during EAE suggests that the
same molecules mediating immune cell entry across the
BBB might be involved in guiding inflammatory cells into
the CVOs. This notion was confirmed by our findings that
both molecules are available on the luminal surface of
CVO microvessels, with the exception of the median emi-
nence, where luminal VCAM-1 could not be detected.
Inflammatory cells within the CVOs were found to stain
positive for Mac-1+ and LFA-1+, therefore resemling those,
present in the inflammatory cuffs surrounding brain
venules forming a barrier [26]. In contrast, whereas during
EAE inflammatory cells within the brain express high lev-
els of α4-integrins [26] only few α4-integrin+ leukocytes
were found within the CVOs. These observations indicate
that inflammatory cell recruitment into the CVOs is not
necessarily mediated by the same mechanisms as those
regulating leukocyte recruitment across the inflamed BBB,
which during EAE was shown to be mainly dependent on
α4-integrin and VCAM-1[1,25].
Whether immune cells enter the brain or CSF via the
CVOs cannot be determined by this study. It is, however,
tempting to speculate that CVOs have an active role in
determining inflammatory cell recruitment into the brain
as we observed a significantly increased number of
inflammatory cuffs and infiltrating cells in close vicinity
to the CVOs as compared to regions of the brain with a
greater distance to the CVOs. These observations suggest
that during EAE the inflamed CVOs deliver cellular or
molecular signals into the CNS, which may influence
immune cell entry into the CNS and CSF.
Conclusion
Taken together our observations demonstrate that the
CVOs are involved in the immunopathogenesis of EAE.
Considering their strategic localization within the walls of
the ventricles, they may be involved in immune cell entry
from the blood into the CNS parenchmyma and also from
the blood into the CSF. Therefore, the development of
neuroprotective strategies will require consideration of
Localization of inflammatory cell infiltrates in the brain of  mice suffering from EAE are enriched in close vicinity to  CVOs Figure 9
Localization of inflammatory cell infiltrates in the 
brain of mice suffering from EAE are enriched in 
close vicinity to CVOs. During EAE, CD45+ cellular infil-
trates in the brain were found to be enriched in close vicinity 
to CVOs. The top panel shows the SFO with perivascular 
CD45+ cells present within the CVO. Massive CD45+ infil-
trates are prominent within the ventricular walls and the 
brain parenchyma outside but in close vicinity to SFO. The 
bottom panel shows the AP with perivascular and parenchy-
mal CD45+ cells present within this CVO. Many CD45+ cells 
have accumulated at the border between the AP and the 4th 
ventricle. These pictures are representative for the finding 
that CD45+ inflammatory cell infiltrates in the brain were 
found to be enriched in number and size in close vicinity to 
CVOs during EAE. Immunoperoxidase, hematoxylin counter-
stain. Bar = 100 µm. This result was observed in at least 10 
individual stainings.Cerebrospinal Fluid Research 2005, 2:8 http://www.cerebrospinalfluidresearch.com/content/2/1/8
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the molecular changes in the CVOs during CNS
inflammation.
List of abbreviations
AP area postrema
BBB blood brain barrier
CD cluster of differentiation
CNS central nervous system
CVOs circumventricular organs
EAE experimental autoimmune encephalomyelitis
ICAM-1 intercellular adhesion molecule-1
LFA-1 leukocyte function associated antigen-1
MAdCAM-1 mucosal addressin cell adhesion molecule-1
ME median eminence
MHC major histocompatibility complex
OVLT organum vasculosum of the lamina terminalis
PECAM-1 platelet endothelial cell adhesion molecule -1
SFO subfornical organ
VCAM-1 vascular cell adhesion molecule -1
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